Accretion Pharmaceuticals Limited (NSE:ACCPL)

Revenue by Product

Financials in millions INR. Fiscal year is April - March.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Tablet	133.57M
Tablet Growth	9.12%
Oral Liquid	99.56M
Oral Liquid Growth	17.52%
Capsule	53.68M
Capsule Growth	10.81%
External Preparation	37.50M
External Preparation Growth	29.95%
Oral Powder	9.56M
Oral Powder Growth	1.64%
Other (Inventory or Development Charge)	2.77M

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
India	311.71M
India Growth	6.27%
International	24.93M
International Growth	4722.82%